Navigation Links
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea

18, a topical compound based on the SansRosa technology, for the treatment of redness associated with rosacea and other skin disorders.

Research has shown that compounds can be created by chemically modifying certain tetracyclines and that these new compounds have properties that may make them effective in treating diseases involving inflammation and/or destruction of the body's connective tissues. CollaGenex is evaluating various chemically modified tetracyclines (so called "IMPACS" compounds because they are Inhibitors of Multiple Proteases And CytokineS") to assess whether they are safe and effective in these applications. The Company has a pipeline of innovative product candidates with possible applications in dermatology and other disease states. In addition, CollaGenex has acquired the SansRosa(TM) technology, which consists of a class of compounds that have shown promise in reducing the redness associated with rosacea, and the Restoraderm(R) technology, a unique, proprietary dermal drug delivery system. CollaGenex plans to leverage these platforms to develop a range of topical dermatological products with enhanced pharmacologic and cosmetic properties.

To receive additional information on the Company, please visit our Web site at www.collagenex.com, which does not form part of this press release.

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to the Company's plans, timing and success related to its patent applications and the launch of Oracea for the treatment of inflammatory lesions of rosacea, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. CollaGenex' actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including those factors contained in the most recent Form 10-K for the yea
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
5. New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting
6. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
7. King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of Altace with Hydrochlorothiazide
8. Corcept Therapeutics Announces Phase 3 Study Evaluating Corlux for Psychotic Major Depression Misses Primary Endpoint
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Post Your Comments:
(Date:8/20/2014)... -- Research and Markets  has announced the addition of ... their offering. Global Market Report of Pralmorelin ... and regionally ( Europe , Asia ... Latin America etc.). It captures Pralmorelin market trends, ... on three primary areas; manufacture methods & technology development, market ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: Global Coatings for Medical Devices ... This report analyzes the worldwide markets ... by the following Product Segments: Active Coatings, Protective ... provides separate comprehensive analytics for the US, ...
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today ... diagnostic platform during a special event at the company,s ... , on September 5, 2014. The event, which will ... the ApolloDx website, www.apollodx.com .    ... testing," said Jared Bauer , Co-Founder and Managing ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
(Date:8/21/2014)... OpsAssure, the local start-up offering ... participate in the Harbor Accelerator's 14 week development ... and valuable resources.he Harbor’s goal is to launch ... start-up selected for the program receives a variety ... businesses grow quickly, test markets and become viable ...
(Date:8/21/2014)... August 21, 2014 Recently nominated as the ... quite the journey to be the man he is today. ... always had a positive look on women, respecting them as professionals ... owes gratefulness and thanks to a man who he had the ... Howard Stern. , KC Armstrong’s name will ring a bell to ...
(Date:8/21/2014)... BambooIndustry.com, one of the most famous bamboo product suppliers ... hand scraped bamboo floorings to its online ... offer for these elegant items. According to the company’s ... up to 25% off; the promotion will come to ... looks and available in different varieties, the company’s new ...
(Date:8/20/2014)... Top 10 Best SEO Hosting ... and announced Bluehost ( http://www.bluehost.com/track/seohosts ), MaxCDN, and ... provide high quality PHP hosting at affordable rates. ... SEO Hosting are unbiased and entirely independent, ensuring ... possible. During the recent years, web hosting industry ...
(Date:8/20/2014)... August 21, 2014 On September 7th, 2014 ... MS organization connects people living with MS with people who ... dollars and are 85% of the way to their goal. ... registration begins at 11:30 and the walk starts at ... available to answer question about chiropractic care and how it ...
Breaking Medicine News(10 mins):Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2
... released today the American College of Physicians reaffirmed its ... on Price and Clinical Performance Information, the first paper ... an introduction and overview of the issues and challenges ... that increasing transparency in the health care system can ...
... University of Utah determined that the 2009 pandemic influenza ... in children than the seasonal flu. The most ... details of the study, the most extensive evaluation of ... in the September issue of Annals of Neurology ...
... An international consortium of scientists has discovered new ... affect the risk of ovarian cancer in the general ... online in Nature Genetics . The consortium, ... based the new work on their earlier research comparing ...
... accurately locate breast cancers, reduce the need for second ... spheres of silica, a porous glass, can mark the ... ultrasound imaging in the operating room. A ... of California, San Diego, created the new material, which ...
... The drug pazopanib may help revolutionize the care ... researchers at Mayo Clinic who are publishing findings ... Lancet Oncology . VIDEO ALERT: Additional audio ... Keith Bible describing the research, are available on the ...
... of Kevin Foskett, PhD, the Isaac Ott Professor of Physiology ... a possible new target for fighting cystic fibrosis (CF) that ... in affected CF-related cells. Their finding appears in the ... role of CFTR, the chloride ion channel mutated in CF ...
Cached Medicine News:Health News:Benefits of increased health care transparency hinge on reliable and valid information, says ACP 2Health News:Benefits of increased health care transparency hinge on reliable and valid information, says ACP 3Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2Health News:2 studies find new genetic links to ovarian cancer risk 2Health News:2 studies find new genetic links to ovarian cancer risk 3Health News:Better marker for breast cancer may reduce need for second surgeries 2Health News:Targeted therapy decreases progression rate in thyroid cancer 2Health News:Channeling efforts to fight cystic fibrosis 2
... easy-to-use 3800 and 3900/P pulse oximeters ... the proprietary clinical patient motion algorithm ... improved performance:, ,The 3800 and ... rigorous environmental/ mechanical stress testing such ...
... The Acuity LT Central Monitoring Station provides ... and ready to go right out of ... surveillance in specific care areas rather than ... ICU. As patient-to-caregiver ratios continue to climb ...
... 3800 and 3900/P pulse oximeters are ... proprietary clinical patient motion algorithm from ... performance:, ,The 3800 and 3900 ... environmental/ mechanical stress testing such as ...
... Researchers., ,S/5 Collect and S/5 Collect4 provides ... collect data from Datex-Ohmeda monitors. Data can be ... intervals. With S/5 Collect you have ability to ... interface cable or connect directly from S/5 Central. ...
Medicine Products: